SAN FRANCISCO, April 08, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts NantKwest, Inc. (NASDAQ:NK) investors of the May 23, 2016 lead plaintiff deadline in the securities class action lawsuit related to the Company’s improper accounting related in part to stock-based awards to its Chief Executive Officer/Executive Chairman.
If you suffered over $200,000 in losses because of your purchases of NantKwest between September 10, 2015 and March 10, 2016 or have information that will help our investigation contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing [email protected] or visiting https://www.hbsslaw.com/cases/NK. The lawsuit was filed in the U.S. District Court for the Central District of California and investors have until May 23, 2016 to move the court to participate as a lead plaintiff.
On March 11, 2016, NantKwest announced that its financial statements for the quarters ended June 30, 2015 and September 30, 2015 were no longer reliable due, in part, to the effects of errors attributable to (a) improper accounting for stock based awards to the Company’s Chief Executive Officer and Executive Chairman, Patrick Soon-Shiong, and (b) improper build-to-suit lease accounting related to one of the Company’s research and development and good manufacturing practices facilities. On this news, NantKwest’s stock price fell $0.28, or 3.31%, to close at $8.17 per share on March 11, 2016.
The class action complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (a) NantKwest’s financial statements contained errors related to stock based awards to Patrick Soon-Shiong; (b) the Company’s financial statements contained errors related to build-to-suit lease accounting related to one of the Company’s research and development and good manufacturing practices facilities; (c) the Company’s internal controls were ineffective; and (d) as a result, the Company’s public statements were materially false and misleading at all relevant times.
Whistleblowers: Persons with non-public information regarding NantKwest should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 



